-
Something wrong with this record ?
International quality assurance of human papillomavirus testing
Lena Dillner, Joakim Dillner
Language English Country Czech Republic
Digital library NLK
Full text - Article
Volume
Source
Source
NLK
Free Medical Journals
from 2004
Medline Complete (EBSCOhost)
from 2006-03-01 to 6 months ago
- MeSH
- Molecular Diagnostic Techniques standards utilization MeSH
- Papillomavirus Infections diagnosis immunology MeSH
- Clinical Laboratory Techniques methods instrumentation utilization MeSH
- Humans MeSH
- Mass Screening methods standards utilization MeSH
- Reference Standards MeSH
- Quality Control MeSH
- Serology methods standards MeSH
- Guidelines as Topic MeSH
- World Health Organization MeSH
- Papillomavirus Vaccines MeSH
- Check Tag
- Humans MeSH
To contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, WHO has initiated a global HPV LabNet. The LabNet tasks are to facilitate implementation of standardized, state-of-the-art HPV laboratory methods by introducing international standards, proficiency testing reagents/methods, standard operating procedures and quality assurance (QA) programs in order to make results comparable across laboratories worldwide. The LabNet is also intended to form the basis for development of a global network for HPV surveillance by using standardized and harmonized laboratory methodologies in order to provide sound data to policy-makers. The LabNet is composed of 2 global reference laboratories (GRL) and 1-2 regional reference laboratories (RRL) in each WHO region. The GRL provide coordination of the network, lead development of QA programs and perform confirmatory testing of samples from regions. The GRL also oversee the HPV prevalences and vaccination impact worldwide through collaboration with RRL. Eventually, a formalized global HPV laboratory network will provide HPV surveillance and vaccination impact evaluation in an internationally harmonized way. Effective HPV surveillance programs will be an essential component of appropriately implemented HPV vaccination programs. Such surveillance should be based on internationally standardised and quality assured laboratory methods in order to make results comparable across laboratories in the world.
HPV in Human Pathology. Prague, Czech Republic, May 1-3, 2008
Bibliography, etc.Lit.: 2
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11039784
- 003
- CZ-PrNML
- 005
- 20150319090445.0
- 008
- 111111s2008 xr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Dillner, Lena
- 245 10
- $a International quality assurance of human papillomavirus testing / $c Lena Dillner, Joakim Dillner
- 314 __
- $a WHO HPV LabNet Global Reference Laboratory, Malmö
- 500 __
- $a HPV in Human Pathology. Prague, Czech Republic, May 1-3, 2008
- 504 __
- $a Lit.: 2
- 520 9_
- $a To contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, WHO has initiated a global HPV LabNet. The LabNet tasks are to facilitate implementation of standardized, state-of-the-art HPV laboratory methods by introducing international standards, proficiency testing reagents/methods, standard operating procedures and quality assurance (QA) programs in order to make results comparable across laboratories worldwide. The LabNet is also intended to form the basis for development of a global network for HPV surveillance by using standardized and harmonized laboratory methodologies in order to provide sound data to policy-makers. The LabNet is composed of 2 global reference laboratories (GRL) and 1-2 regional reference laboratories (RRL) in each WHO region. The GRL provide coordination of the network, lead development of QA programs and perform confirmatory testing of samples from regions. The GRL also oversee the HPV prevalences and vaccination impact worldwide through collaboration with RRL. Eventually, a formalized global HPV laboratory network will provide HPV surveillance and vaccination impact evaluation in an internationally harmonized way. Effective HPV surveillance programs will be an essential component of appropriately implemented HPV vaccination programs. Such surveillance should be based on internationally standardised and quality assured laboratory methods in order to make results comparable across laboratories in the world.
- 650 _2
- $a infekce papilomavirem $x diagnóza $x imunologie $7 D030361
- 650 _2
- $a klinické laboratorní techniky $x metody $x přístrojové vybavení $x využití $7 D019411
- 650 _2
- $a referenční standardy $7 D012015
- 650 _2
- $a řízení kvality $7 D011786
- 650 _2
- $a vakcíny proti papilomavirům $7 D053918
- 650 _2
- $a plošný screening $x metody $x normy $x využití $7 D008403
- 650 _2
- $a sérologie $x metody $x normy $7 D012699
- 650 _2
- $a diagnostické techniky molekulární $x normy $x využití $7 D025202
- 650 _2
- $a Světová zdravotnická organizace $7 D014944
- 650 _2
- $a směrnice jako téma $7 D017408
- 650 _2
- $a lidé $7 D006801
- 700 1_
- $a Dillner, Joakim
- 773 0_
- $w MED00001083 $t Central European journal of public health $g Roč. 16,Suppl. (2008), s. S18-S20 $x 1210-7778
- 773 0_
- $t Central European journal of public health $g Roč. 16,Suppl. (2008), s. S18-S20 $w MED00001083
- 856 41
- $u https://cejph.szu.cz/pdfs/cjp/2008/88/08.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 1829 $c 562 $y 2 $z 0
- 990 __
- $a 20111109144052 $b ABA008
- 991 __
- $a 20150319090729 $b ABA008
- 999 __
- $a ok $b bmc $g 885962 $s 750167
- BAS __
- $a 3
- BMC __
- $a 2008 $b 16 $c Suppl. $d S18-S20 $m Central European Journal of Public Health $x MED00001083
- BMC __
- $a 2008 $b 16 $c Suppl. $d S18-S20 $m HPV in human pathology $x MED00170653
- LZP __
- $a 2011-CEJPH